Delivery Order SPE2DB20D3111-SPE2DB25FA7VP

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,691.83 firm fixed-price order is for OLUMIANT 2 MG TABLET 30S, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,397.99, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,105.96, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used for various medical conditions. The contract has an ultimate completion date of August 15, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside and is open to full and...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of 4567156621 - OLUMIANT 4 MG...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,023.41 and an ultimate completion date of August 29, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and medical supplies to the U.S....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,098.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565393817 OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 9, 2024 and is not a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $3,601.87 firm fixed-price delivery order is for the supply of 4565404288 ! OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,603.11 with a completion date of March 18, 2025. It is for the supply of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of various medical conditions. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,923.08 firm fixed price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a prescription medication, to support military healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 4564042960 OLUMIANT 2 MG TABLET 30S. The order, valued at $1,940.78, has a performance period through March 22, 2024. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation and serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA7VP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OLUMIANT 2 MG TABLET 30S. The contract has a ceiling value of $30,262.56 and is a firm fixed-price delivery order. The ultimate completion date is May 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/18/25, 9:51 AM